Product Code: ETC12010638 | Publication Date: Apr 2025 | Updated Date: Jun 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The India drug eluting balloon market is experiencing significant growth due to the increasing prevalence of cardiovascular diseases in the country. Drug eluting balloons are widely used in the treatment of coronary artery disease and peripheral artery disease, providing a minimally invasive and effective treatment option. The market is driven by advancements in technology, rising healthcare expenditure, and growing awareness about the benefits of these devices among both healthcare professionals and patients. Key players in the market are focusing on product innovation and strategic collaborations to expand their market presence. However, challenges such as high costs associated with these devices and the availability of alternative treatment options may hinder market growth to some extent. Overall, the India drug eluting balloon market is poised for continued expansion in the coming years.
The India drug-eluting balloon market is currently experiencing growth due to factors such as increasing prevalence of cardiovascular diseases, rising adoption of minimally invasive procedures, and advancements in technology. Key trends in the market include a growing focus on product innovation to enhance treatment outcomes, rising demand for drug-eluting balloons in the treatment of complex lesions, and strategic collaborations among key players to expand their market presence. Additionally, the market is witnessing a shift towards value-based healthcare models, increasing awareness about the benefits of drug-eluting balloons, and expanding distribution networks to reach a wider patient population. Overall, the India drug-eluting balloon market is poised for further expansion driven by technological advancements and increasing demand for minimally invasive treatment options.
The India drug eluting balloon market faces several challenges, including regulatory hurdles, pricing pressures, and competition from alternative treatments. The regulatory landscape in India is complex and often creates delays in the approval process for new drug eluting balloon products. Additionally, pricing pressures from the government and insurance companies can impact the profitability of manufacturers and limit market growth. Furthermore, the market faces stiff competition from other minimally invasive treatment options such as drug-eluting stents and traditional balloon angioplasty. These challenges require companies operating in the India drug eluting balloon market to navigate a complex environment, innovate to differentiate their products, and establish strong relationships with key stakeholders to drive adoption and market growth.
The India drug eluting balloon market presents promising investment opportunities due to factors such as increasing prevalence of cardiovascular diseases, growing adoption of minimally invasive procedures, and advancements in technology. With a rising awareness about the benefits of drug eluting balloons in preventing restenosis post angioplasty, the market is expected to witness significant growth in the coming years. Additionally, collaborations between medical device companies and healthcare providers to improve patient outcomes and reduce healthcare costs further enhance the market potential. Investors can consider opportunities in companies involved in the manufacturing, distribution, and marketing of drug eluting balloons, as well as those focusing on research and development to introduce innovative products tailored to the needs of the Indian market.
The Indian government has implemented various policies related to the drug eluting balloon market to ensure safety, efficacy, and accessibility. The National Pharmaceutical Pricing Authority (NPPA) regulates the prices of medical devices, including drug eluting balloons, to make them affordable for patients. The Central Drugs Standard Control Organization (CDSCO) governs the approval and registration process for medical devices, ensuring that all products meet quality and safety standards. Additionally, the government has introduced initiatives such as the Make in India campaign to promote domestic manufacturing of medical devices, including drug eluting balloons, reducing dependence on imports and boosting the local industry. These policies aim to create a conducive environment for innovation, growth, and competitiveness in the Indian drug eluting balloon market.
The future outlook for the India drug eluting balloon market appears promising, driven by a growing prevalence of cardiovascular diseases and an increasing demand for minimally invasive treatment options. Factors such as technological advancements in drug eluting balloon technology, rising healthcare expenditure, and improving healthcare infrastructure are expected to further fuel market growth. Additionally, a shift towards outpatient procedures and a focus on reducing healthcare costs through less invasive treatment options are likely to drive adoption of drug eluting balloons in India. However, challenges such as regulatory hurdles, pricing pressures, and the availability of alternative treatments may hinder market growth to some extent. Overall, the India drug eluting balloon market is anticipated to witness steady growth in the coming years, presenting opportunities for both domestic and international manufacturers.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Drug Eluting Balloon Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Drug Eluting Balloon Market Revenues & Volume, 2021 & 2031F |
3.3 India Drug Eluting Balloon Market - Industry Life Cycle |
3.4 India Drug Eluting Balloon Market - Porter's Five Forces |
3.5 India Drug Eluting Balloon Market Revenues & Volume Share, By Coating Type, 2021 & 2031F |
3.6 India Drug Eluting Balloon Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 India Drug Eluting Balloon Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Drug Eluting Balloon Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 India Drug Eluting Balloon Market Trends |
6 India Drug Eluting Balloon Market, By Types |
6.1 India Drug Eluting Balloon Market, By Coating Type |
6.1.1 Overview and Analysis |
6.1.2 India Drug Eluting Balloon Market Revenues & Volume, By Coating Type, 2021 - 2031F |
6.1.3 India Drug Eluting Balloon Market Revenues & Volume, By Paclitaxel-Eluting Balloons, 2021 - 2031F |
6.1.4 India Drug Eluting Balloon Market Revenues & Volume, By Sirolimus-Eluting Balloons, 2021 - 2031F |
6.1.5 India Drug Eluting Balloon Market Revenues & Volume, By Everolimus-Eluting Balloons, 2021 - 2031F |
6.1.6 India Drug Eluting Balloon Market Revenues & Volume, By Zotarolimus-Eluting Balloons, 2021 - 2031F |
6.2 India Drug Eluting Balloon Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 India Drug Eluting Balloon Market Revenues & Volume, By Coronary Artery Disease (CAD), 2021 - 2031F |
6.2.3 India Drug Eluting Balloon Market Revenues & Volume, By Peripheral Artery Disease (PAD), 2021 - 2031F |
6.2.4 India Drug Eluting Balloon Market Revenues & Volume, By In-Stent Restenosis (ISR), 2021 - 2031F |
6.2.5 India Drug Eluting Balloon Market Revenues & Volume, By Bypass Graft Disease, 2021 - 2031F |
6.3 India Drug Eluting Balloon Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 India Drug Eluting Balloon Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 India Drug Eluting Balloon Market Revenues & Volume, By Cardiology Clinics, 2021 - 2031F |
6.3.4 India Drug Eluting Balloon Market Revenues & Volume, By Ambulatory Surgical Centers, 2021 - 2031F |
6.3.5 India Drug Eluting Balloon Market Revenues & Volume, By Research Institutions, 2021 - 2031F |
7 India Drug Eluting Balloon Market Import-Export Trade Statistics |
7.1 India Drug Eluting Balloon Market Export to Major Countries |
7.2 India Drug Eluting Balloon Market Imports from Major Countries |
8 India Drug Eluting Balloon Market Key Performance Indicators |
9 India Drug Eluting Balloon Market - Opportunity Assessment |
9.1 India Drug Eluting Balloon Market Opportunity Assessment, By Coating Type, 2021 & 2031F |
9.2 India Drug Eluting Balloon Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 India Drug Eluting Balloon Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India Drug Eluting Balloon Market - Competitive Landscape |
10.1 India Drug Eluting Balloon Market Revenue Share, By Companies, 2024 |
10.2 India Drug Eluting Balloon Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |